Atropine Sulfate
NDC Package 0641-6006-10
Package Information
Atropine Sulfate is a medication used before eye examinations (e.g., refraction) and to treat certain eye conditions (e.g., uveitis). Marketed by Hikma Pharmaceuticals Usa Inc., this product is identified by NDC 0641-6006.
Identification & Billing
- RxCUI: 1190776 - atropine sulfate 0.4 MG/ML Injectable Solution
- RxCUI: 1190776 - atropine sulfate 1 MG per 2.5 ML Injectable Solution
- RxCUI: 1190776 - atropine sulfate 1.2 MG per 3 ML Injectable Solution
- RxCUI: 1190776 - atropine sulfate 2 MG per 5 ML Injectable Solution
- RxCUI: 1190776 - atropine sulfate 8 MG per 20 ML Injectable Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0641 - Hikma Pharmaceuticals Usa Inc.
- 0641-6006 - Atropine Sulfate
- 0641-6006-10 - 10 VIAL in 1 CARTON / 20 mL in 1 VIAL (0641-6006-01)
- 0641-6006 - Atropine Sulfate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0641-6006-10 identifies a specific commercial package of 10 vial in 1 carton / 20 ml in 1 vial (0641-6006-01) of Atropine Sulfate, labeled by Hikma Pharmaceuticals Usa Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Hikma Pharmaceuticals Usa Inc. on January 01, 1971. The current certification is valid through December 31, 2025.
What are the primary indications for this medication?
This medication is used before eye examinations (e.g., refraction) and to treat certain eye conditions (e.g., uveitis). It belongs to a class of drugs known as anticholinergics. Atropine works by widening (dilating) the pupil of the eye.
How is this Hikma Pharmaceuticals Usa Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00641600610. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.